82671-55-4 Usage
Uses
Used in Pharmaceutical and Agrochemical Synthesis:
2,6-dimethyl-4-(4-nitrophenyl)pyridine is used as a key intermediate in the synthesis of pharmaceuticals and agrochemicals for its ability to contribute to the formation of active compounds with specific therapeutic or pesticidal properties.
Used in Dye and Pigment Production:
In the dye and pigment industry, 2,6-dimethyl-4-(4-nitrophenyl)pyridine is used as a precursor to create a variety of dyes and pigments, leveraging its chemical structure to produce vibrant and stable colorants.
Used as a Chemical Reaction Reagent:
2,6-dimethyl-4-(4-nitrophenyl)pyridine is utilized as a reagent in a range of chemical reactions due to its reactivity, facilitating the synthesis of complex organic compounds and aiding in various transformation processes.
Used in Chemical Analysis and Research:
DNPP is employed as an analytical reagent in chemical research, where its high reactivity and distinctive properties are harnessed for the detection, quantification, and study of other chemical substances, contributing to the advancement of scientific knowledge and understanding of chemical systems.
Used as a Building Block for Complex Compounds:
In the realm of organic chemistry, 2,6-dimethyl-4-(4-nitrophenyl)pyridine serves as a building block for the creation of more complex compounds, providing a foundation upon which additional functional groups and structural elements can be added to achieve desired chemical and physical properties.
Check Digit Verification of cas no
The CAS Registry Mumber 82671-55-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,2,6,7 and 1 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 82671-55:
(7*8)+(6*2)+(5*6)+(4*7)+(3*1)+(2*5)+(1*5)=144
144 % 10 = 4
So 82671-55-4 is a valid CAS Registry Number.
82671-55-4Relevant articles and documents
BICYCLIC KINASE INHIBITORS AND USES THEREOF
-
Paragraph 613; 666; 667, (2021/11/06)
The invention relates to kinase inhibitors, in particular inhibitors of protein kinases including the SIK-family, CSF1R, HCK, TEK-family, BRK, ABL, KIT and/or their mutants. Although structurally similar to other bicyclic kinase inhibitors, the kinase inhibitors of the invention are distinctive; possessing a particular class of heterocyclic moiety. Such kinase inhibitors can display one or more certain properties distinct to their structurally similar kinase inhibitors. The kinase inhibitors of the invention or pharmaceutical compositions comprising them may be used in the treatment of a disorder or condition, such as a proliferative disorder, for example, a leukaemia or solid tumour. In particular, these and other structurally related kinase inhibitors may be used in the treatment of a proliferative disorder - such as a mixed phenotype acute leukaemia (MPAL) - characterised by (inter-alia) the presence of MEF2C protein, a human chromosomal translocation at 11q23, and/or a KMT2A fusion oncoprotein. The kinase inhibitors or pharmaceutical compositions of the invention may be used topically to modulate skin pigmentation in a subject, for example to impart UV protection and reduce skin cancer risk.
NITRATION OF ALKYL-SUBSTITUTED 4-ARYL(BENZOYL)PYRIDINES
Prostakov, N. S.,Soldatenkov, A. T.,Krapivko, A. P.,Fomichev, A. A.,Mikaya, A. I.,Ustenko, A. A.
, p. 958 - 963 (2007/10/02)
The nitration of 4-aryl- and 4-benzoylpyridines substituted with alkyl groups in the pyridine ring was realized.The isomeric nitro products were identified by analysis of the PMR spectra and by chromato-mass spectrometry.The dependence of the ratio of the obtained isomers on the strucutre of the initial compounds was established.
